| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/05/1985 | EP0143367A2 Method for production of monoclonal antibodies for cancer diagnosis and therapy |
| 06/05/1985 | EP0143345A2 Use of hyperimmune milk for the manufacture of a medicament for the treatment of cardio-vascular diseases or for lowering lipid bloodstream levels |
| 06/04/1985 | US4521593 Process for obtaining lacto-N-norhexaosyl ceramide |
| 06/04/1985 | US4521513 Protection against dental caries |
| 06/04/1985 | US4521405 Mixture of histamine and measles virus immunmogen |
| 06/04/1985 | US4521334 Synthetic polypeptide fragments |
| 06/04/1985 | CA1188244A1 Angiotropins of leukocytes and inflamed tissue and process for their preparation |
| 06/04/1985 | CA1188220A1 Preparation of detoxified e. coli neurotoxin and obtained products |
| 05/29/1985 | EP0142905A2 Therapeutic substance for treating diseases such as cancer |
| 05/29/1985 | EP0142634A1 Method and reagent for use in the assay of PIVKA-II |
| 05/28/1985 | US4520226 Treatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: ricin conjugates |
| 05/28/1985 | US4520113 Strip radioimmunoassy or enzyme-linked immunoassay |
| 05/28/1985 | CA1187793A2 Vaccine and method of making |
| 05/23/1985 | WO1985002261A1 Method for detecting immune complexes in serum |
| 05/23/1985 | WO1985002258A1 Novel immunoassays and kits for use therein |
| 05/23/1985 | WO1985002188A1 Novel monoclonal antibody |
| 05/23/1985 | WO1985002121A1 Immune response to tumors and viruses induced by anti-idiotype antibodies |
| 05/22/1985 | EP0142387A1 Process for the preparation of vaccines specific for LH and HCG and process for their detection |
| 05/22/1985 | EP0142345A2 Anti-idiotypic vaccine employing anti-idiotypic monoclonal antibodies |
| 05/22/1985 | EP0142193A1 Preparation of immunogens consisting of antigens and/or antigenic determinants bound to glycoside-containing carriers |
| 05/22/1985 | EP0142192A1 Preparation of immunogens consisting of antigenic determinates bound to glycoside-containing carriers |
| 05/21/1985 | CA1187641A1 High impact compositions containing polycyano norbornenes, halogenated polyolefin and abs resin |
| 05/21/1985 | CA1187413A1 High titer production of hepatitis a virus background of the invention |
| 05/21/1985 | CA1187410A1 Pasteurized therapeutically active protein compositions |
| 05/21/1985 | CA1187387A1 Reagent strip test for antithrombin-iii |
| 05/15/1985 | EP0141783A2 Immune response to tumours and viruses induced by anti-idiotype antibodies |
| 05/15/1985 | EP0141671A2 Bordetella bronchiseptica pilus subunit protein vaccine, composition of matter, and processes for their preparation |
| 05/15/1985 | EP0141620A2 Specific binding assay reagent |
| 05/15/1985 | EP0141616A2 Hybrid cell lines producing monoclonal antibodies directed against trichomonas vaginalis determinants |
| 05/15/1985 | EP0141458A1 Deletion mutant of a herpesvirus and vaccine containing said virus |
| 05/15/1985 | EP0141079A2 Monoclonal antibodies specific for membrane-associated antigens |
| 05/14/1985 | US4517304 Production of viral antigens |
| 05/14/1985 | CA1186994A1 Therapeutic method and method for making compositions for use therein |
| 05/14/1985 | CA1186993A1 Protein (pp in16 xx), a process for concentrating and isolating it, and its use |
| 05/08/1985 | EP0140787A2 Magnetic means for the removal of magnetic gel particles from a test fluid |
| 05/08/1985 | EP0140762A1 Vectors for the expression of an antigenic rabies protein in eukaryotic cells, and their use in the preparation of a vaccine |
| 05/08/1985 | EP0140728A1 Cytotoxic pharmaceutical association, especially suited for the treatment of cancers |
| 05/08/1985 | EP0140689A2 Hybrid cell lines producing monoclonal antibodies directed against treponema and use thereof for immuno-diagnosis of treponemal infections |
| 05/08/1985 | EP0140627A2 Production of livestock or products derived therefrom |
| 05/08/1985 | EP0140521A2 Specific binding assay |
| 05/08/1985 | EP0140498A1 Caries-preventive composition |
| 05/08/1985 | EP0140489A1 Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances |
| 05/08/1985 | EP0140386A2 Method for the purification of LPF-HA |
| 05/08/1985 | EP0140379A2 Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies |
| 05/08/1985 | EP0139746A1 Enhanced agglutination method and kit |
| 05/07/1985 | US4515891 Process for the production of disaccharide-tripeptide and disaccharide-tetrapeptide |
| 05/07/1985 | US4515777 Against reo and newcastle viruses |
| 05/07/1985 | US4515776 Removal of aggregates |
| 05/07/1985 | US4515715 Immunostimulants, immunoadjuvants |
| 05/07/1985 | US4515714 Chromatography on sulfated, crosslinked cellulose or polysaccharide |
| 05/07/1985 | CA1186629A1 Biologically active substance, process for preparing the substance and immunoactive composition |
| 05/07/1985 | CA1186628A1 Antigens comprising immunostimulant adjuvants and their use in immunotherapy |
| 05/07/1985 | CA1186627A1 Process for making novel blood clotting enzyme compositions |
| 05/07/1985 | CA1186620A2 Composition and method for detecting cancer with technetium labeled antibody fragments |
| 05/02/1985 | EP0139555A1 Synthetic peptide, process for its preparation, and drugs thereof |
| 05/02/1985 | EP0139552A1 Compound labelled with acetylcholine sterase from Electrophorus electricus, method for its preparation and its use as a marker in enzyme immuno assays |
| 05/02/1985 | EP0139526A2 An insolubilized stable specific binding protein |
| 05/02/1985 | EP0139417A1 Vaccines based on membrane bound proteins and process for making them |
| 05/02/1985 | EP0139416A2 Molecularly cloned diagnostic product and method of use |
| 05/02/1985 | EP0139389A1 Antiidiotypic monoclonal antibody reagents and immunoassays employing antiidiotypic monoclonal antibody reagents |
| 05/02/1985 | EP0139316A1 Method for the immunochemical determination of hepatitis B core antigens |
| 05/02/1985 | EP0139216A2 Adult T cell leukemia virus antigen peptide |
| 04/30/1985 | US4514506 Method for the identification and purification of human lung tumor-associated antigens (hLTAA) and clinical detection and determination of these antigens |
| 04/30/1985 | US4514498 Urogential disorders |
| 04/30/1985 | US4514497 Modified live pseudorabies viruses |
| 04/30/1985 | CA1186223A1 Isolation of principal outer membrane protein and antigen of chlamydia trachomatis |
| 04/30/1985 | CA1186222A1 Immunochemical reagent |
| 04/30/1985 | CA1186221A1 Composition and method for detecting cancer with technetium labeled antibody fragments |
| 04/30/1985 | CA1186219A1 Method for determining allergic sensitivity |
| 04/25/1985 | WO1985001659A1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/24/1985 | EP0138704A2 Hepatitis A-subunit antigen |
| 04/24/1985 | EP0138685A2 Immunoassay methods and compositions |
| 04/24/1985 | EP0138667A2 Method for the diagnosis of lymphadenopathy and acquired immune depression syndrome |
| 04/24/1985 | EP0138377A1 Lewis blood group phenotype assay |
| 04/24/1985 | EP0138297A1 Immuno-agglutination particle suspensions |
| 04/24/1985 | EP0138242A1 Method of preparing DNA complementary to the genome of coronaviruses |
| 04/24/1985 | EP0138222A2 Preparation of monoclonal anti-protein C antibodies |
| 04/24/1985 | EP0138167A1 Method for purification of HBs antigen |
| 04/24/1985 | EP0138101A1 Genetically engineered organisms expressing surface proteins of T. Cruzi |
| 04/24/1985 | EP0137822A1 Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems. |
| 04/23/1985 | US4512978 Dermatological composition useful in the treatment of psoriasis |
| 04/23/1985 | US4512972 Contains krestin |
| 04/23/1985 | CA1185899A1 Refined detoxified endotoxin product |
| 04/17/1985 | EP0137678A1 Ultrasonic enhanced immuno-reactions |
| 04/17/1985 | EP0137515A2 Bioluminescent immunoassays |
| 04/17/1985 | EP0137457A2 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
| 04/17/1985 | EP0137234A2 Physiologically active compositions |
| 04/16/1985 | US4511556 Inactivation of a lipid virus |
| 04/16/1985 | CA1185549A1 Method for the preparation of an improved mutant strain of bordetella bronchiseptica useful as a live attenuated vaccine for prophylaxis of b. bronchiseptica infection |
| 04/11/1985 | WO1985001580A1 Immunoassay for serum antibodies with liposome reagent having destabilization component |
| 04/11/1985 | WO1985001517A1 PRODUCTION OF cDNA REPRESENTING HEPATITIS A VIRAL SEQUENCES |
| 04/11/1985 | WO1985001516A1 Vectors for the expression of an antigenic protein of rabies in eucaryotic cells and application thereof to the preparation of a vaccine |
| 04/10/1985 | EP0136947A2 Conjugated lipopolysaccharides, process for their preparation and their use as immunizing agents |
| 04/10/1985 | EP0136938A2 Derivatives of furanes, their preparation and application |
| 04/10/1985 | EP0136932A2 Method and materials for development of immunological responses protective against malarial infection |
| 04/10/1985 | EP0136835A2 Process for the preparation of antibody compositions of therapeutic agents having an extended serum half-life |
| 04/10/1985 | EP0136347A1 Insoluble surfaces treated to inhibit non-specific protein binding |
| 04/09/1985 | US4510129 Mixture of antigen and neuraminidase |
| 04/09/1985 | CA1185236A1 Immunologically active dipeptidyl saccharides and methods of preparation |
| 04/03/1985 | EP0136215A2 Method and materials for development of immunological responses protective against malarial infection |